Redox Therapeutics signs agreement to develop life-saving filtration technology

On April 29, 2025, in Philadelphia, Pennsylvania, Redox Therapeutics, a healthcare company, announced an exclusive license agreement with The Curators of the University of Missouri, specifically through the Missouri University of Science and Technology (Missouri S&T). This agreement aims to utilize a patented technology involving polymer nanoparticles designed to effectively remove endotoxins from various fluids, including water, protein solutions, and plasma. Redox Therapeutics is looking to combat sepsis, a significant public health issue and leading cause of death, especially in hospitals, where endotoxins are recognized as a primary factor contributing to this condition. The World Health Organization reports that sepsis and septic shock are linked to over 11 million deaths annually, emphasizing the need for effective treatments. Despite extensive research efforts in recent decades, effective solutions to influence the outcomes of sepsis remain limited. Redox Therapeutics aims to bridge this therapeutic gap by developing a blood filtration system that incorporates their licensed technology, which has demonstrated the potential to eliminate up to 100% of endotoxins in laboratory tests. In addition to addressing healthcare challenges, Redox Therapeutics recognizes the broader implications of endotoxins in polluted industrial and wastewater systems, which are critical to public health. Their initiative represents a two-fold approach, targeting both healthcare and environmental needs. Leonard Neatu, MD, the founder and CEO of Redox Therapeutics, expressed enthusiasm for licensing and bringing this promising technology to market, anticipating that it could significantly impact sepsis treatment and save countless lives. Missouri S&T's Kamal H. Khayat, Vice Chancellor for Research and Innovation, also voiced support for the collaboration, expressing optimism about the positive societal impact the filtration technology could provide. The partnership signifies a continued dedication to innovation and public health solutions, with Redox's commitment to not only ensuring effective endotoxin removal but also making these solutions affordable and widely accessible.